Fate Therapeutics
FATE
#9512
Rank
HK$0.97 B
Marketcap
HK$8.00
Share price
-10.53%
Change (1 day)
6.13%
Change (1 year)

P/S ratio for Fate Therapeutics (FATE)

P/S ratio as of November 2026 (TTM): 19.1

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.8089. At the end of 2026 the company had a P/S ratio of 37.7.

P/S ratio history for Fate Therapeutics from 2013 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202637.7120.26%
202517.127.27%
202413.5131.76%
20235.80-42.99%
202210.2-89.82%
2021100-60.36%
202025281.87%
2019139-20.75%
2018175123.55%
201778.3231.94%
201623.6-40.72%
201539.8
2014N/A-100%
2013132

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Becton Dickinson
BDX
2.82-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
0.8022-95.80%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
4.36-77.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
4.54-76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
600 3,036.99%๐Ÿ‡บ๐Ÿ‡ธ USA